72.11.Z - Research and experimental development on biotechnology
19.20.Z - Manufacture and processing ofrefind petroleum products
46.19.Z - Agents involved in the sale of a variety of goods
46.71.Z - Wholesale of fuels and related products
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
64.19.Z - Other monetary intermediation
64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,6 | 0,3 | -0 | -111,6 |
Gross profit (loss) | 0,6 | 0,3 | -0 | -112,4 |
EBITDA | 0,6 | 0,3 | -0 | -109,2 |
Short time liabilities | 0 | 0 | 0,1 | -∞ |
Other operating costs | 0 | 0 | 0 | -92,1 |
Equity capital | 0,6 | 0,9 | 0,8 | -5,8 |
Operating profit (EBIT) | 0,6 | 0,3 | -0 | -111,9 |
Assets | 0,6 | 1,1 | 1 | -10,4 |
Net profit (loss) | 0,6 | 0,3 | -0,1 | -115,2 |
Cash | 0 | 0,3 | 0,2 | -38,9 |
Net income from sale | 1,2 | 1,1 | 1 | -12,2 |
Liabilities and provisions for liabilities | 0 | 0 | 0,1 | -∞ |
Working assets | 0,6 | 1,1 | 1 | -12,6 |
Other income costs | 0 | 0 | 0 | -93,1 |
Depreciation | 0 | 0 | 0 | 59,8 |
% | % | % | p.p. | |
Profitability of capital | 99,9 | 38,2 | -6,2 | -44,4 |
Equity capital to total assets | 93,5 | 80,9 | 85 | 4,1 |
Gross profit margin | 46,6 | 30,3 | -4,3 | -34,6 |
EBITDA Margin | 46,7 | 30,9 | -3,3 | -34,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 12 | 0 | 55 | 55 |
Current financial liquidity indicator | 15.08029842376709 | 6.471209526062012 | -8,6 | |
Net dept to EBITDA | -0.051776181906461716 | -0.4114833474159241 | 3.8081724643707275 | 4,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane